You searched for metabolic diseases - Page 14 of 62

PBC clinical trials: Gannex doses first patient

News and Trends 15 Sep 2022

Tridek-One brings in €16M to develop auto-immune diseases candidates

…will primarily be used to identify development candidates against auto-immune diseases, to conduct IND-enabling studies and to further build the organization. The company previously raised €3 million ($3 million) in…

September 15, 2022 - 2 minutesmins - By Jim Cornall

In Depth 21 Mar 2024

Biotech in France: What’s holding back progress and how to move forward?

…rare diseases in Europe. However, France’s biotech ecosystem faces a set of challenges. While France’s position offers a glimpse into the potential for groundbreaking health solutions, it also opens up…

March 21, 2024 - 8 minutesmins - By Jules Adam

More News! 9 Nov 2022

PrecisionLife supports Sosei Heptares to treat chronic diseases in more personalized way

PrecisionLife, developers of precision medicine for chronic diseases, will be supporting biopharmaceutical group, Sosei Heptares, to develop better, more personalized treatment options. Specifically, global techbio PrecisionLife, will assess the precision…

November 9, 2022 - 3 minutesmins - By Liza Laws

Best in Biotech 30 May 2024

Stem cell therapy’s avant-garde: Eight companies leading the way

…of chronic and degenerative diseases, such as cardiovascular diseases, neurodegenerative disorders, and cancer, drives the demand for advanced therapeutic options like stem cell therapy that can repair and regenerate damaged…

May 30, 2024 - 11 minutesmins - By Jules Adam

News and Trends 29 Jun 2022

Encouraging results from respiratory diseases vaccine trial

A biopharmaceutical company developing vaccines against infectious diseases has announced positive results for people with life threatening respiratory diseases. Icosavax says that in an interim phase 1/1b trial its vaccine…

June 29, 2022 - 4 minutesmins - By Liza Laws

Trump’s healthcare cabinet picks: Implications for U.S. biopharma

News and Trends 29 Nov 2024

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

…of over 95,000 children and confirmed that the MMR vaccine did not increase the risk for autism spectrum disorder. Moreover, vaccines have eradicated deadly diseases such as smallpox. The threat…

November 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

Expert Advice 27 May 2020

Why Listening to Patient Organizations is Key in Drug Development

…space, it is still a challenge for patient organizations to get biotech and pharma companies involved in developing drugs for rare diseases. Because the majority of rare diseases are not…

May 27, 2020 - 11 minutesmins - By Larissa Warneck-Silvestrin

In Depth 15 Jan 2025

CRISPR: The gene editing tool changing the world (2025 update)

…are already seeing CRISPR-based programs focusing on a wide diversity of diseases. CRISPR Therapeutics, for instance, in addition to Casgevy, is developing programs for cardiovascular diseases, type 1 diabetes, as…

January 15, 2025 - 9 minutesmins - By Jules Adam

Interview 5 Feb 2020

Harnessing Genetic Suppression to Treat Rare Disease

…this genetic resilience to treat rare diseases and cancer. Heritable diseases result from genetic mutations that cause essential proteins in the body to malfunction. For example, people with the condition…

February 5, 2020 - 5 minutesmins - By Jonathan Smith

Startup Scout 13 Oct 2017

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

This week we’re in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson’s, depression and schizophrenia. Mission: Neurolixis…

October 13, 2017 - 2 minutesmins - By Alex Dale

News and Trends 23 Jan 2018

Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug

…metabolic disorder that affects children from a young age. It belongs to a group of diseases called Lysosomal Storage Disorders as the body cannot break down heparan sulfate, a long…

January 23, 2018 - 2 minutesmins - By Alex Dale

News and Trends 17 Jul 2023

Lilly boosts obesity portfolio with Versanis Bio acquisition

…on the development of new medicines for the treatment of cardiometabolic diseases. Versanis’ lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to…

July 17, 2023 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Tridek-One brings in €16M to develop auto-immune diseases candidates

Biotech in France: What’s holding back progress and how to move forward?

PrecisionLife supports Sosei Heptares to treat chronic diseases in more personalized way

Stem cell therapy’s avant-garde: Eight companies leading the way

Encouraging results from respiratory diseases vaccine trial

Trump’s healthcare picks: Who they are and what they mean for the biopharma industry

Why Listening to Patient Organizations is Key in Drug Development

CRISPR: The gene editing tool changing the world (2025 update)

Harnessing Genetic Suppression to Treat Rare Disease

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug

Lilly boosts obesity portfolio with Versanis Bio acquisition

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!